Pharma Early Development
Preclinical drug development is a complex, regulatory and strategy-driven process. The most important element of the preclinical process is to select the best new molecular entities to enter into the clinical trials and to limit failure in full development. With its countless years of professional experience in drug development Eurofins is well positioned to offer a holistic approach of the compound development in order to maximize the chances of success in the clinical phases.
Our network of expertise and full service is not only a matter of convenience but also an issue of confidence and security to succeed with your project. Our clients select Eurofins for this distinctive match of expertise, flexibility and full service. This beneficial setting explains why we work for 8 out of the 10 biggest Pharma companies.